Alkynylnicotinamide-Based Compounds as ABL1 Inhibitors with Potent Activities against Drug-Resistant CML Harboring ABL1(T315I) Mutant Kinase
2018 ◽
Vol 13
(12)
◽
pp. 1172-1180
◽
Elizabeth A. Larocque
◽
N. Naganna
◽
Clement Opoku-Temeng
◽
Alyssa M. Lambrecht
◽
Herman O. Sintim
2018 ◽
Vol 13
(12)
◽
pp. 1159-1159
Elizabeth A. Larocque
◽
N. Naganna
◽
Clement Opoku-Temeng
◽
Alyssa M. Lambrecht
◽
Herman O. Sintim
2006 ◽
Vol 2006
◽
pp. 185
2005 ◽
Vol 35
(22)
◽
pp. 24
A Dressler
◽
E Reithofer
◽
B Stöcklin
◽
F Benninger
◽
M Freilinger
◽
...
T Hartlieb
◽
T Pieper
◽
S Kessler-Uberti
◽
HC Eitel
◽
T Getzinger
◽
...